[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy]

Rafael Laredo1, Lorenzo Monserrat, Manuel Hermida-Prieto

  • 1Servicio de Cardiología, Complejo Hospitalario Universitario Juan Canalejo e Instituto Universitario de Ciencias de la Salud de la Universidad de A Coruña, A Coruña, Spain.

Insights

Mutations in the beta-myosin heavy-chain gene (MYH7) were found in 10% of hypertrophic cardiomyopathy (HCM) families. These MYH7 mutations were more common in patients with severe hypertrophy or a family history of sudden death.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Basis of Cardiomyopathies

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
  • Genetic mutations are a known cause of HCM, impacting cardiac function.
  • Identifying specific gene mutations aids in understanding disease progression and inheritance patterns.

Purpose of the Study:

  • To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with HCM.
  • To investigate the correlation between specific MYH7 genotypes and the clinical phenotypes observed in HCM patients and their families.

Main Methods:

  • Single-strand conformation polymorphism analysis and gene sequencing were performed on 128 index patients with HCM.
  • Phenotypes of patients with and without identified MYH7 mutations were compared.
  • Phenotypic data from affected families with identified mutations were systematically recorded.

Main Results:

  • Eleven MYH7 mutations were identified in 13 families (10% prevalence).
  • Mutations were more frequent in patients with severe hypertrophy (>=30 mm thickness) and a family history of sudden death.
  • Sudden death occurred in eight family members across four families, linked to specific MYH7 mutations like I736T.

Conclusions:

  • MYH7 mutations are found in 10% of hypertrophic cardiomyopathy families, often associated with severe disease and sudden cardiac death.
  • The genotype-phenotype correlation for MYH7 mutations can be variable, suggesting potential influence from other genetic or environmental factors.
  • Further research is needed to identify additional genetic factors contributing to phenotypic variability in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...